A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : r-axSpA / radiographic axial spondyloarthritis

[Related PubMed/MEDLINE]
Total Number of Papers: 26
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   r-axSpA  (>> Co-occurring Abbreviation)
Long Form:   radiographic axial spondyloarthritis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Associations between syndesmophytes and facet joint ankylosis in radiographic axial spondyloarthritis patients on low-dose CT over 2 years. FJA, LDCT, VU
2022 Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials. IXE, nr-axSpA
2022 Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis. TNFi
2022 Facet joint disease in patients with axial spondyloarthritis: A retrospective computed tomography study. CT, FJ, nr-AxSpA
2022 Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials. ASQoL, bDMARDs, CI, EQ-5D, HRQoL, IL-17A, MCS, PCS, RCTs, TNF
2022 Increased risks of aortic regurgitation and atrial fibrillation in radiographic axial spondyloarthritis patients: a 10-year nationwide cohort study. AF, AV, GP, HRs, PYs, SIRs
2022 Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging. CRP, PBO
2022 Low-dose CT hounsfield units: a reliable methodology for assessing vertebral bone density in radiographic axial spondyloarthritis. HU, ICC, LDCT
2022 Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study. CRP, MRI, PA, SI, SIJ
10  2022 The role of LCN2 and LCN2-MMP9 in spondylitis radiographic development: gender and HLA-B27 status differences. LCN2, LM, SIJ
11  2021 Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis. nr-axSpA, SIJ, SPARCC
12  2021 Association between facet joint ankylosis and functional impairment in patients with radiographic axial spondyloarthritis. BASFI, CTSS, ICCs, LDCT
13  2021 Elucidating the role of a positive family history in differentiating between axial and peripheral spondyloarthritis: an ancillary analysis of the ASAS-PerSpA study. FDR, PFH, pSpA, SDR, SpA
14  2021 Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results. ASAS, BASDAI, bDMARD, TNFi
15  2021 Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials. ASAS, NSAIDs
16  2021 Potential Role and Impact of Peripheral Blood Mononuclear Cells in Radiographic Axial Spondyloarthritis-Associated Endothelial Dysfunction. ED, HDs, PBMCs
17  2021 Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years. IXE, mSASSS
18  2020 Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-alpha therapy effectiveness. HDs, IFX, NET, TNF
19  2020 Facet joint ankylosis in r-axSpA: detection and 2-year progression on whole spine low-dose CT and comparison with syndesmophyte progression. ICCs, LDCT, SDC, SIAS
20  2020 Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies. ADA, bDMARD, EQ-5D-5L, IXE, PBO, TNFi
21  2020 No relationship between bone mineral density and syndesmophyte formation at the same level in the lumbar spine of patients with radiographic axial Spondyloarthritis. BMD, GEE
22  2019 Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts. AS, ASAS, mNY
23  2019 Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). ASAS40, bDMARD, PBO, TNFi
24  2019 Evaluation of subclinical myocardial dysfunction using speckle tracking echocardiography in patients with radiographic and non-radiographic axial spondyloarthritis. AS, GLS, STE
25  2018 Is radiographic progression in radiographic axial spondyloarthritis related to matrix metalloproteinase degradation of extracellular matrix? ECM, mSASSS, OASIS
26  2017 The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology. AS, ASAS, FDA, USA, mNY, nr-axSpA, TNFi